Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/9829
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCharles, Patrick G Pen
dc.contributor.authorGrayson, M Lindsayen
dc.date.accessioned2015-05-15T23:05:07Z
dc.date.available2015-05-15T23:05:07Z
dc.date.issued2004-11-15en
dc.identifier.citationMedical Journal of Australia; 181(10): 549-53en
dc.identifier.govdoc15540967en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/9829en
dc.description.abstractThe emergence and spread of multidrug-resistant pathogens has increased substantially over the past 20 years. Over the same period, the development of new antibiotics has decreased alarmingly, with many pharmaceutical companies pulling out of antibiotic research in favour of developing "lifestyle" drugs. Reasons given for withdrawing from antibiotic development include poor "net present value" status of antibiotics, changes in regulations requiring larger drug trials and prolonged post-marketing surveillance, clinical preference for narrow-spectrum rather than broad-spectrum agents, and high new-drug purchase costs. Major improvements in infection control in Australia are needed to prevent further spread of resistant clones, buying some time to develop urgently needed new antibiotic agents. Perpetuating a culture of "pharma bashing" will simply lead to more pharmaceutical companies withdrawing from the market. A change in the health and research culture is needed to improve cooperation between public, academic and private sectors.en
dc.language.isoenen
dc.subject.otherAnti-Bacterial Agents.therapeutic useen
dc.subject.otherDrug Industryen
dc.subject.otherDrug Resistanceen
dc.subject.otherDrug and Narcotic Controlen
dc.subject.otherHumansen
dc.subject.otherProduct Surveillance, Postmarketingen
dc.subject.otherTherapeutic Equivalencyen
dc.titleThe dearth of new antibiotic development: why we should be worried and what we can do about it.en
dc.typeJournal Articleen
dc.identifier.journaltitleMedical Journal of Australiaen
dc.identifier.affiliationInfectious Diseases Department, Austin Health, Heidelberg, VIC.en
dc.description.pages549-53en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/15540967en
dc.type.austinJournal Articleen
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptGeneral Medicine-
crisitem.author.deptInfectious Diseases-
crisitem.author.deptInfectious Diseases-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

4
checked on Feb 7, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.